chloramphenicol has been researched along with fosfomycin in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (33.33) | 18.7374 |
1990's | 3 (7.69) | 18.2507 |
2000's | 10 (25.64) | 29.6817 |
2010's | 11 (28.21) | 24.3611 |
2020's | 2 (5.13) | 2.80 |
Authors | Studies |
---|---|
Duewelhenke, N; Eysel, P; Krut, O | 1 |
Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Bernabeu, S; Nordmann, P; Poirel, L; Revathi, G | 1 |
Barros, MT; Dias, R; Faísca Phillips, AM; Pacheco, M | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chico Rizzo, E | 1 |
Kong, YL; Miller, AK; Stapley, EO | 1 |
Daza, RM; Mendaza, MP; Perea, EJ | 1 |
Hardisson, C; Llaneza, J | 1 |
Altés Gutiérrez, A; Rodríguez Noriega, A | 1 |
Borobio, MV; Perea, EJ; Torres, MA | 1 |
Baquero, G; Figueroa, J; Otal, C; Rodríguez, A | 1 |
Triolo, R | 1 |
Mengin-Lecreulx, D; van Heijenoort, J | 1 |
Sawae, Y | 1 |
Ball, P; Chopra, I | 1 |
Hayashi, K | 1 |
Daneo-Moore, L; Kral, TA | 1 |
Dixon, PA; Gilbert, PJ; White, DJ | 1 |
Guggenbichler, JP | 1 |
Deguchi, K; Ishihara, R; Ishii, Y; Nakazawa, A; Suzuki, Y | 1 |
Barbé, G; Bercion, R; Boucaud-Maitre, Y; Boyer, M; Carricajo, A; Célard, M; Chomarat, M; Clergeau, P; Croizé, J; Delubac, F; Fèvre, D; Fredenucci, I; Fuhrmann, C; Gilles, Y; Gravagna, B; Helfre, M; Lelièvre, H; Letouzey, MN; Mandjee, A; Marchal, MF; Marthelet, P; Meley, R; Perrier-Gros-Claude, JD; Reverdy, ME; Ros, A; Roure, C; Sabot, O; Smati, S; Thierry, J; Tixier, A; Tous, J; Verger, P; Zaoui, E | 1 |
Tabata, M; Takata, T; Tsuruoka, T; Watabe, H | 1 |
Falagas, ME; Kopterides, P | 1 |
Falagas, ME; Grammatikos, AP; Michalopoulos, A | 1 |
Blázquez, J; López, E | 1 |
Ono, Y | 1 |
Cegelski, L; Nygaard, R; Rice, DM; Romaniuk, JAH | 1 |
Chen, Y; Fu, Y; Hua, X; Ji, J; Jiang, Y; Li, X; Liu, L; Pi, B; Quan, J; Yang, Y; Yu, Y | 1 |
Dushkin, AV; Gaidul, KV; Goldina, IA; Lykov, AP | 1 |
Bressan, R; Cervoni, M; Di Bella, S; Imperi, F; Lagatolla, C; Luzzati, R; Milic, J | 1 |
Burzyńska, N; Empel, J; Grinholc, M; Woźniak, A; Zybała, I | 1 |
5 review(s) available for chloramphenicol and fosfomycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Transport of antibiotics into bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Biological Transport; Biological Transport, Active; Butylene Glycols; Cell Membrane; Cephalosporins; Chloramphenicol; Cycloserine; Energy Metabolism; Ferrous Compounds; Fosfomycin; Iron; Models, Biological; Organophosphonates; Penicillins; Peptides; Peptides, Cyclic; Peptidoglycan; Showdomycin; Streptozocin; Tetracyclines | 1982 |
Other antibiotics.
Topics: Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Colistin; Erythromycin; Fosfomycin; Humans; Lincomycin; Orthopedics; Polymyxin B; Tetracyclines; Vancomycin | 1984 |
Old antibiotics for infections in critically ill patients.
Topics: Anti-Bacterial Agents; Chloramphenicol; Critical Illness; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Fosfomycin; Fusidic Acid; Gentamicins; Humans; Polymyxins | 2007 |
Potential of old-generation antibiotics to address current need for new antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Chloramphenicol; Colistin; Drug Resistance, Bacterial; Drug Utilization; Fosfomycin; Fusidic Acid; Humans; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
34 other study(ies) available for chloramphenicol and fosfomycin
Article | Year |
---|---|
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Detection of NDM-1-producing Klebsiella pneumoniae in Kenya.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Kenya; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction | 2011 |
Synthesis and biological evaluation of α-hydroxyalkylphosphonates as new antimicrobial agents.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Organophosphonates; Structure-Activity Relationship | 2014 |
Antibiotic treatment of respiratory sepsis.
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalosporins; Chloramphenicol; Cloxacillin; Fosfomycin; Gentamicins; Haemophilus Infections; Humans; Methicillin; Penicillin G; Polymyxins; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Staphylococcal Infections; Streptococcal Infections | 1976 |
Fosfomycin treatment of Haemophilus influenzae infection in mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cephaloridine; Cephalothin; Chloramphenicol; Fosfomycin; Haemophilus Infections; Haemophilus influenzae; Injections, Subcutaneous; Mice; Penicillins; Tetracycline | 1977 |
Genetic localization of the resistance to fosfomycin.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Conjugation, Genetic; Enterobacteriaceae; Escherichia coli; Fosfomycin; Klebsiella; Penicillin Resistance; Recombination, Genetic; Streptomycin; Transduction, Genetic | 1977 |
The action of fosfomycin on the growth of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Chloramphenicol; Culture Media; Drug Interactions; Drug Resistance, Microbial; Erythromycin; Fosfomycin; Lincomycin; Mutation; Oxygen Consumption; Phosphates; Pseudomonas aeruginosa; Sulfadiazine; Tetracycline; Time Factors | 1977 |
In vitro sensitivity of anaerobic bacteria to fosfomycin.
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides; Cephalothin; Chloramphenicol; Clindamycin; Clostridium; Fosfomycin; Lincomycin; Penicillin Resistance; Penicillins; Peptococcus; Peptostreptococcus; Tetracycline; Veillonella | 1977 |
Synergism of fosfomycin-ampicillin and fosfomycin-chloramphenicol against Salmonella and Shigella.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Drug Synergism; Fosfomycin; Microbial Sensitivity Tests; Salmonella; Shigella | 1978 |
Treatment of typhoid fever with fosfomycin alone and associated to chloramphenicol or ampicillin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Child; Chloramphenicol; Drug Combinations; Drug Evaluation; Drug Synergism; Female; Fosfomycin; Humans; Injections, Intramuscular; Male; Middle Aged; Time Factors; Typhoid Fever | 1977 |
[Nephrotoxicity of antibiotics].
Topics: Aminoglycosides; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antifungal Agents; Cephalosporins; Chloramphenicol; Erythromycin; Fosfomycin; Humans; Kidney Diseases; Penicillins; Peptides; Rifampin; Tetracyclines | 1976 |
Correlation between the effects of fosfomycin and chloramphenicol on Escherichia coli.
Topics: Bacteriolysis; Chloramphenicol; Escherichia coli; Fosfomycin; Glucosyltransferases; N-Acetylglucosaminyltransferases; Nucleotides; Peptidoglycan | 1990 |
[Miscellaneous antibiotics].
Topics: Administration, Oral; Bacterial Infections; Chloramphenicol; Colistin; Fosfomycin; Humans; Injections; Polymyxin B; Vancomycin | 1990 |
Effects of cell wall inhibitors on cell division in Streptococcus mutans.
Topics: Anti-Bacterial Agents; Bacteriolysis; Cell Division; Cell Wall; Chloramphenicol; Chromosomes; Cycloserine; DNA Replication; Fosfomycin; Mitomycin; Mitomycins; Penicillin G; Streptococcus mutans; Vancomycin | 1983 |
Mutagenicity of antibiotics in microbial assays. Problems of evaluation.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Chromosome Deletion; Drug Resistance, Microbial; Escherichia coli; Fosfomycin; Gene Conversion; Gentamicins; Microsomes, Liver; Mutagenicity Tests; Oleandomycin; Rats; Saccharomyces cerevisiae; Salmonella typhimurium; Species Specificity; Tetracycline | 1980 |
[Purulent meningitis in children. II. Treatment and prognosis].
Topics: Ampicillin; Child; Child, Preschool; Chloramphenicol; Cortisone; Electrolytes; Fluid Therapy; Fosfomycin; Humans; Infant; Meningitis; Meningitis, Haemophilus; Meningitis, Pneumococcal; Penicillin G; Prognosis; Shock, Septic | 1982 |
[The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157].
Topics: Aerobiosis; Ampicillin; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter jejuni; Cefaclor; Cephalosporins; Chloramphenicol; Drug Resistance, Microbial; Enteritis; Escherichia coli O157; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Penicillins; Salmonella; Tetracycline; Vibrio parahaemolyticus | 1997 |
[Rhône-Alpes observatory of Streptococcus pneumoniae in 1999: 35 cases of meningitis].
Topics: Adolescent; Adult; Aged; Amoxicillin; Cefotaxime; Child; Child, Preschool; Chloramphenicol; Drug Resistance, Microbial; Female; Fosfomycin; France; Humans; Infant; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Middle Aged; Penicillins; Retrospective Studies; Rifampin; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2002 |
[Activity of fosfomycin against Escherichia coli O157:H7--morphological changes and production of Shiga toxins].
Topics: Ampicillin; Anti-Bacterial Agents; Bacteriolysis; Cell Wall; Chloramphenicol; Dose-Response Relationship, Drug; Escherichia coli O157; Fosfomycin; Kanamycin; Norfloxacin; Shiga Toxins | 2003 |
Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Chloramphenicol; Chromosomes, Bacterial; Ciprofloxacin; Colistin; Escherichia coli; Fosfomycin; Gentamicins; Imipenem; Microbial Sensitivity Tests; Recombination, Genetic; Rifampin; Tetracycline; Trimethoprim | 2009 |
[Antibiotics].
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Chloramphenicol; Fosfomycin; Glycopeptides; Humans; Ketolides; Linezolid; Macrolides; Oxazolidinones; Peptides; Streptogramins; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Spectral snapshots of bacterial cell-wall composition and the influence of antibiotics by whole-cell NMR.
Topics: Anti-Bacterial Agents; Carbon; Cell Wall; Chloramphenicol; Fosfomycin; Magnetic Resonance Spectroscopy; Nitrogen; Peptidoglycan; Polysaccharides, Bacterial; Protein Synthesis Inhibitors; Protoplasts; Staphylococcus aureus; Teichoic Acids | 2015 |
Abrp, a new gene, confers reduced susceptibility to tetracycline, glycylcine, chloramphenicol and fosfomycin classes in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Cell Proliferation; Chloramphenicol; Drug Resistance, Bacterial; Fosfomycin; Genes, Bacterial; Membrane Potentials; Microbial Sensitivity Tests; Peptide Hydrolases; Tetracyclines | 2016 |
[CLINICAL EFFICACY OF TREATMENT OF STAPHYLOCOCCAL INFECTION BY COMPOSITION OF NANOSTRUCTURED SILICON DIOXIDE AND FOSFOMYCIN.]
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Drug Compounding; Fosfomycin; Male; Nanoparticles; Polymers; Rabbits; Silicon Dioxide; Skin; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome | 2017 |
Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Disease Models, Animal; Drug Synergism; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Kaplan-Meier Estimate; Microbial Sensitivity Tests; Moths; Sepsis; Vancomycin-Resistant Enterococci | 2021 |
Priming effect with photoinactivation against extensively drug-resistant Enterobacter cloacae and Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Chloramphenicol; Colistin; Enterobacter cloacae; Fosfomycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Photosensitizing Agents; Rose Bengal | 2022 |